吸烟、呼出气一氧化碳与帕金森病风险
规律吸烟与帕金森病风险降低相关(调整HR 0.70,95%CI 0.62-0.79)。在从不吸烟者中,呼出气一氧化碳水平较高与帕金森病风险降低呈剂量依赖关联,且未见于其他神经退行性疾病或吸烟相关疾病。
要点
- 规律吸烟者帕金森病风险降低,调整HR为0.70(95%CI 0.62-0.79)。
- 该关联在女性从不吸烟者中更明显,支持CO在帕金森病病因中的潜在保护作用。
核心结论
- 在从不吸烟者中,较高的呼出气一氧化碳水平与较低的帕金森病风险相关,提示CO在帕金森病病因中可能具有保护作用。
研究设计与样本
- 前瞻性分析限定于40至94岁之间、2019年1月1日前发生的首次事件,数据分析时间为2025年5月至2026年3月。
主要发现
- 约12年随访期间,通过链接全国死亡与疾病登记及医保系统记录1131例帕金森病和2949例其他神经退行性疾病。
- 规律吸烟与肺癌、缺血性心脏病、卒中和全因死亡风险升高相关,但与帕金森病风险降低相关(调整HR 0.70,95%CI 0.62-0.79)。
- 从不吸烟者中,呼出气CO与吸烟相关疾病或其他神经退行性疾病风险无关联。
- 呼出气CO与帕金森病的关联在女性从不吸烟者中更明显,在规律吸烟者中也发现类似关联。
关键数值与推荐
- 规律吸烟者平均呼出气CO为11.1 ppm,从不吸烟者为3.5 ppm,偶尔吸烟者为3.8 ppm,既往规律吸烟者为3.7 ppm。
临床怎么用
- 呼出气CO作为易获取的暴露标志物,可能有助于识别帕金森病风险较低的人群,但当前证据来自观察性队列,尚不能用于临床干预决策。
- 该发现为正在进行的CO治疗帕金森病临床试验提供了流行病学支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Smoking has been associated with lower risks of Parkinson disease (PD) in epidemiological studies, but the underlying mechanisms remain poorly elucidated. OBJECTIVE: To investigate the association of exhaled carbon monoxide (CO) with risk of PD. DESIGN, SETTING, AND PARTICIPANTS: This nationwide prospective cohort study leveraged data from the China Kadoorie Biobank across 10 geographically diverse areas in China. A total of 512 724 adults aged 30 to 79 years were recruited between June 2004 and July 2008. Prospective analyses were restricted to first events occurring between ages 40 and 94 years and before January 1, 2019. Data were analyzed from May 2025 to March 2026. EXPOSURE: Self-reported smoking status and measured exhaled CO. MAIN OUTCOMES AND MEASURES: During approximately 12 years' follow-up, 1131 individuals with PD and 2949 with other neurodegenerative diseases were recorded through linkage to national death and disease registries and the health insurance system. Cox regression was used to estimate adjusted hazard ratios (HRs) for associations of smoking and, among individuals who never smoked, exhaled CO levels with PD, other neurodegenerative diseases, and several known smoking-related diseases. Covariates included sociodemographic characteristics, lifestyle factors, and other confounders (ie, solid fuel use and passive exposure to smoking). RESULTS: Among the 512 701 participants included in the main analyses, the mean (SD) age was 52 (11) years and 302 041 (58.9%) were female. Overall, 156 650 male individuals (74.5%) and 9944 female individuals (3.3%) ever smoked regularly, with mean exhaled CO levels higher among those who regularly smoked (11.1 ppm) than those who never smoked (3.5 ppm), those who occasionally smoked (3.8 ppm), and those who formerly smoked regularly (3.7 ppm). Regular smoking was significantly associated with elevated risks of lung cancer, ischemic heart disease, stroke, and all-cause mortality but with lower risk of PD (adjusted HR, 0.70; 95% CI, 0.62-0.79). In individuals who never smoked, higher exhaled CO levels were associated with lower HRs of PD (n = 675) in a broadly dose-dependent manner (exhaled CO <2.0 ppm: 1.00 [95% CI, 0.85-1.18]; 2.0 to <3.0: 0.85 [95% CI, 0.73-0.99]; 3.0 to <5.0: 0.62 [95% CI, 0.53-0.73]; 5.0 to <11.5: 0.68 [95% CI, 0.56-0.83]; ≥11.5: 0.65 [95% CI, 0.45-0.92]; P for trend < .001) but were not associated with risks of smoking-related diseases or other neurodegenerative diseases. The associations with PD were more pronounced in female individuals who never smoked. Similar exhaled CO-PD associations were found in those who regularly smoked. CONCLUSION AND RELEVANCE: Among individuals who never smoked, higher exhaled CO levels were associated with lower PD risk. These findings demonstrate a potentially protective role of CO in PD etiology, which help explain the association between smoking and PD observed in this and other epidemiological studies and support ongoing clinical trials of CO in the treatment of PD.
引用
- Bueno Lopez C, Iona A, Turnbull I, et al. Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease. JAMA Neurol. 2026. PMID: 42709430. doi:10.1001/jamaneurol.2026.3037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。